359 related articles for article (PubMed ID: 31974915)
1. Interleukin-35 Suppresses CD8
Yang L; Zhang Q; Song J; Wang W; Jin Z
Dig Dis Sci; 2020 Dec; 65(12):3614-3623. PubMed ID: 31974915
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-35 Dampens CD8
Yang L; Shao X; Jia S; Zhang Q; Jin Z
Front Immunol; 2019; 10():1032. PubMed ID: 31134088
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-37 suppresses the cytotoxicity of hepatitis B virus peptides-induced CD8+ T cells in patients with acute hepatitis B.
Liu Q; Zhou Q; Wang M; Pang B
Biomol Biomed; 2023 May; 23(3):527-534. PubMed ID: 36326182
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell RNA Sequencing Shows T-Cell Exhaustion Landscape in the Peripheral Blood of Patients with Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure.
Yao J; Ji Y; Liu T; Bai J; Wang H; Yao R; Wang J; Zhou X
Gut Liver; 2024 May; 18(3):520-530. PubMed ID: 37317515
[TBL] [Abstract][Full Text] [Related]
6. [PD-1 is associated with CD8(+)T lymphocyte dysfunction in patients with acute and chronic liver failure].
Chang L; Zhang X; Zhang YP; Qin DY; Liu WJ; Chai B; Yao J
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1101-1105. PubMed ID: 34933430
[No Abstract] [Full Text] [Related]
7. Interleukin-35 Suppresses Interleukin-9-Secreting CD4
Zhang Q; Yang L; Liu S; Zhang M; Jin Z
Front Immunol; 2021; 12():645835. PubMed ID: 34177894
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-35 has a Protective Role in Infectious Mononucleosis-Induced Liver Inflammation Probably by Inhibiting CD8
Gao Y; Li L; Hu X; Zhang W; Li Y
Arch Immunol Ther Exp (Warsz); 2022 Oct; 70(1):25. PubMed ID: 36219249
[TBL] [Abstract][Full Text] [Related]
9. Increased Circulating T Follicular Helper Cells Induced
Du B; Teng J; Yin R; Tian Y; Jiang T; Du Y; Cai W
Front Immunol; 2021; 12():641362. PubMed ID: 33868273
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease.
Sun M; Xing H
Int Immunopharmacol; 2021 Jul; 96():107642. PubMed ID: 33862556
[TBL] [Abstract][Full Text] [Related]
11. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-7 promotes CD8
Tian X; Su Z; Guo S; Wang C; Zhang X; Du J
Int Immunopharmacol; 2019 Oct; 75():105773. PubMed ID: 31349155
[TBL] [Abstract][Full Text] [Related]
13. Imbalance Between Soluble and Membrane-Bound CD100 Regulates Monocytes Activity in Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure.
Zhang DN; Liu Y; Li X; Gao Y; Xi FY; Li Y; Zhu GZ
Viral Immunol; 2021 May; 34(4):273-283. PubMed ID: 33646067
[TBL] [Abstract][Full Text] [Related]
14. Notch signaling pathway suppresses CD8
Li S; Wang Z; Li XJ
Int Immunopharmacol; 2018 Oct; 63():129-136. PubMed ID: 30086535
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma.
Liu S; Yang L; Jia S; Zhao R; Jin Z
Int Immunopharmacol; 2021 Nov; 100():108161. PubMed ID: 34555643
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-7 augments CD8
Hou H; Kang Y; Zeng Y; Li Y; Shang J
Cytokine; 2018 Feb; 102():26-33. PubMed ID: 29275010
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-35 suppresses antitumor activity of circulating CD8
Liu MX; Liu QY; Liu Y; Cheng ZM; Liu L; Zhang L; Sun DH
Connect Tissue Res; 2019 Jul; 60(4):367-375. PubMed ID: 30616389
[No Abstract] [Full Text] [Related]
18. Overexpression of ascitic interleukin-35 induces CD8
Yang L; Liu S; Zhang Q; Jia S; Qiu C; Jin Z
Int Immunopharmacol; 2022 Jul; 108():108729. PubMed ID: 35349961
[TBL] [Abstract][Full Text] [Related]
19. Activation of Toll-like receptor 2 enhances peripheral and tumor-infiltrating CD8
Xu J; Guo R; Jia J; He Y; He S
BMC Immunol; 2021 Oct; 22(1):67. PubMed ID: 34620075
[TBL] [Abstract][Full Text] [Related]
20. The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.
Yu X; Guo R; Ming D; Deng Y; Su M; Lin C; Li J; Lin Z; Su Z
Clin Vaccine Immunol; 2015 May; 22(5):484-92. PubMed ID: 25716231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
